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PURPOSE. A two-generation consanguineous Pakistani family with autosomal recessive Leber con-
genital amaurosis (LCA, MIM 204,000) and keratoconus was identified. All affected individuals have
bilateral keratoconus and congenital pigmentary retinopathy. The goal of this study was to link the
disease phenotype in this family.
METHODS. Genomic DNA was amplified across the polymorphic microsatellite poly-CA regions
identified by markers. Polymerase chain reaction (PCR) products were separated by nondenaturing
polyacrylamide gel electrophoresis. Alleles were assigned to individuals, which allowed calculation
of LOD scores using the Cyrillic and MLINK software program. The retinal guanylate cyclase
(RETGC-1, GDB symbol GUC2D) and pigment epithelium-derived factor (PEDF) genes were
analyzed by heteroduplex analysis and direct sequencing for mutations in diseased individuals.
RESULTS. Based on a whole genome linkage analysis the first locus for this combined phenotype has
been mapped to chromosome 17p13. Linkage analysis gave a two point LOD score of 3.21 for
marker D17S829. Surrounding this marker is a region of homozygosity of 15.77 cM, between the
markers D17S1866 and D17S960; however, the crossover for the marker D17S1529 refines the
region to 10.77 cM within which the disease gene is predicted to lie. Mutation screening of the
nearby RETGC-1 gene, which has been shown to be associated with LCA1, revealed no mutations
in the affected individuals of this family. Similarly, another prime candidate in the region PEDF was
also screened for mutations. The factor has been shown to be involved in the photoreceptor
differentiation and neuronal survival. No mutations were found in this gene either. Furthermore,
RETGC-1 was physically excluded from the critical disease region based on the existing physical
map.
CONCLUSIONS. It is therefore suggested that this combined phenotype maps to a new locus and is due
to an as yet uncharacterized gene within the 17p13 chromosomal region. (Invest Ophthalmol Vis
Sci. 2000;41:629–633)
Leber congenital amaurosis (LCA) is a clinically heteroge-neous group of childhood retinal degenerations inher-ited in an autosomal recessive manner. It is diagnosed at
birth or during the first few months of life. Infants are totally
blind or have greatly impaired vision, a fundal appearance
ranging from normal to pigmented, and an extinguished elec-
troretinogram (ERG).1 Hypermetropia and keratoconus fre-
quently develop in the course of the disease. Until now very
little has been known about the pathophysiology of the dis-
ease, but LCA is usually regarded as the consequence of either
impaired development of photoreceptors or extremely early
degeneration of cells that have developed normally. LCA is
genetically heterogeneous; it has recently been shown to be
associated with mutations in the RETGC-1 (17p13.1), RPE65
(1p31), and CRX (19q13.3) genes.2–5 Further heterogeneity
has been revealed by the demonstration of linkage to a novel
locus on chromosome 14q24 by Stockton et al.6
Anterior keratoconus is a bilateral noninflammatory pro-
gressive corneal ectasia with an incidence of between 50 and
230 per 100,000 in the general population, dependent on the
clinical detection method used and diagnostic criteria ap-
plied.7,8 There are a number of well-described clinical signs,
including stromal thinning, conical protrusion, a ring-like dep-
osition of iron around the base of the cone (Fleischer’s ring),
fine vertical lines in the deep stroma and Descemet’s mem-
brane (Vogt’s striae), anterior stromal scarring, and enlarged
corneal nerves. Gross alterations in the corneal curvature can
be detected by retroillumination techniques; however, early or
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mild forms of the disease may go undetected unless the ante-
rior corneal topography is studied with computer-assisted
videokeratography. The disease is rarely congenital but usually
appears at puberty, and although one eye may be affected first,
the condition is always eventually bilateral. Corneal distortion
and scaring lead to irregular astigmatism, myopia, and mild-to-
marked impairment of vision. The occurrence of breaks in
Descemet’s membrane can lead to acute hydrops, swelling of
the adjacent cornea due to localized edema, and acute ectasia,
resulting in a sudden marked decrease in visual acuity. Electron
microscopy suggests that the earliest histopathologic changes
may occur in the corneal epithelium. The basal cells appear to
degenerate and release proteolytic enzymes that destroy un-
derlying stromal tissue. Stromal keratocytes near the cone also
show degenerative changes, as does the endothelium, the
latter leading to localized overproduction of Descemet’s mem-
brane.9,10
Keratoconus is most commonly an isolated disorder, al-
though it has been described in association with a large num-
ber of ocular and systemic disorders, and there is an estab-
lished association with Down’s syndrome, mitral valve
prolapse, and LCA.9,10 The study of families of keratoconus
patients provides evidence for a genetic role in the etiology of
keratoconus.8 Although there is an established association be-
tween Down’s syndrome and keratoconus, the karyogram of
the patients of this family did not have trisomy 21. In the family
presented the keratoconus is associated with LCA.
Here we provide data supporting the first genetic linkage
of LCA with keratoconus to chromosome 17p13.1. RETGC-1
gene has been physically mapped in this region and is known
to be associated with LCA1 therefore; it was the possible
candidate for this phenotype. RETGC-1 is predominantly found
in the cone outer segments of the retina, suggesting that the
high RETGC-1 activity in cones may be responsible for the
rapid recovery of cGMP concentration to the dark level.11
Although RETGC-1 maps just outside our critical region, mu-
tation screening for this gene was done to exclude the possi-
bility of this gene being responsible for this phenotype.
The pigment epithelium-derived factor (PEDF) gene has
also been mapped to the short arm of chromosome 17, distal to
the recoverin gene locus and very close to the RP13 locus in a
large South African family.12 PEDF, a 50-kDa protein secreted
by human fetal retinal pigment epithelial cells, is a neurotro-
phic factor that may aid the development, differentiation, and
survival of the adjacent neural retina. The wider distribution of
PEDF mRNA in the central nervous system suggests that this
factor could have pleotrophic, neurotrophic, and neuroprotec-
tive effects on nonretinal neurons as well.13 The gene for PEDF
is highly expressed by both fetal human and young adult retinal
pigment epithelium cells. No mutation has yet been reported
in PEDF gene in any of the eye disorder except few polymor-
phic variations.14 However, because this gene lies within our
critical region, mutation screening for this gene has also been
carried out.
METHODS
A two-generation consanguineous Pakistani family in which
LCA and keratoconus affected four living members was ascer-
tained (Fig. 1). Ophthalmic examination of the unaffected
parents revealed no evidence of keratoconus or LCA. In addi-
tion, nine siblings were examined and found to be unaffected.
Clinical examination of the affected individuals revealed bilat-
eral ectasia with central thinning of the cornea, before they
reach their 20s. The central cornea has a pronounced cone
shape with severe corneal clouding (Fig. 2). All affected indi-
viduals were blind from birth, with absence of rod and cone
function as demonstrated by ERG. Patients also showed bone
spicule pigmentation of the retina. With the informed consent
of the family, peripheral blood samples were collected and
used for genetic analysis. Blood samples were also collected
from 50 unrelated normal individuals of Pakistani origin and
were used as controls for allele frequencies and mutation
screening.
Genomic DNA was extracted from whole blood using the
Nucleon II extraction kit (Scotlab Bioscience) and used to
amplify polymorphic microsatellite markers (Research Genet-
ics) using the polymerase chain reaction (PCR).
FIGURE 1. (A) Photograph of the cornea of an affected member of the
family showing keratoconus; central cornea has a pronounced cone
shape with severe corneal clouding. (B) Photograph of the fundus of
an affected member of the family showing nasal inferior midperiphery
of left eye. Note the bone spicule pigmentation, atrophic aspect of the
retina, especially in the macular area, narrow blood vessels, waxy optic
disc, and a generalized grayish sheen of the retina.
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Microsatellite and Linkage Analysis
Genomic DNA was amplified using primers that specifically
amplify the polymorphic microsatellite poly-CA regions identi-
fied by markers. PCR products were separated by nondenatur-
ing polyacrylamide gel electrophoresis (Protogel; National Di-
agnostics) and visualized under UV illumination after staining
with ethidium bromide. Alleles were assigned to individuals,
and genotypic data were used to calculate the LOD scores
using the Cyrillic and MLINK software program (Cherwell
Scientific Publishing Ltd, Oxford, UK). Allele frequencies were
calculated from the spouses in this family and a control ethni-
cally matched population. The phenotype was analyzed as an
autosomal recessive trait, with complete penetrance, and a
frequency of 0.0001 for the affected allele.
Mutation Screening
The 18 exons of RETGC-1, which are expressed as protein,
were amplified using the intronic primers and annealing tem-
peratures essentially as described by Perrault et al.2 The excep-
tions were as follows: (1) The 59 portion of exon 2 was
amplified with (forward/reverse, 59-39) primers TTACGG-
GGAGAACCCTAGGGGAGGCCG/AGAGAAGATGGGGTCGC
AAG at an annealing temperature of 68°C; (2) middle portion
of exon 2 CTCTCCGCCGTGTTCACGGT/GCGATCCCGGCT-
TCTTCGGC at 60°C; (3) 39 portion of exon 2 TCCGGTGAAC-
CCTGCGGCCT/TGCCGGCAGGACCAGCCGAC at 68°C; (4) a
different forward primer was used for exon 8, GCATTCTGG-
GACAGTGAGCC; and (5) exons 6 and 7 were amplified with
the same published primers but at lower annealing tempera-
tures of 55°C, exon 11 at 68°C, exon 15 at 58°C, and exon 17
at 68°C.
New intronic forward and reverse primers were designed
for the eight exons of the PEDF gene (Table 1) and were used,
at 55°C annealing temperature, for mutation screening in this
family.
Twenty-five or 50 ml PCRs were performed, each contain-
ing 1.5 mM MgCl2, 0.4 mM each primer, 200 mM each dNTP,
16 mM (NH4)2SO4, 67 mM Tris–HCl (pH 8.8), 0.01% Tween-20,
and 1 U of Taq DNA polymerase (Bioline). After an initial
denaturation for 3 minutes at 94°C, 30 cycles of denaturation at
94°C for 1 minute, annealing at the exon-specific temperature
for 1 minute, and extension at 72°C for 1 minute were per-
formed, with a final extension at 72°C for 3 minutes. The
amplified exons were analyzed by electrophoresis using MDE
gel (National Diagnostics, Atlanta, GA) run at 180 V overnight
using Hoeffer 600S apparatus.15
Direct Sequencing
Products of PCR amplification were sequenced using the
PRISM Ready Reaction Sequencing Kit (Perkin–Elmer, PE Bio-
systems), and the products were analyzed on an ABI 373A XL
automated sequencer. All PCR products were sequenced in the
forward and reverse directions.
FIGURE 2. Pedigree of consanguin-
eous Pakistani family with keratoco-
nus and LCA showing homozygosity
of the disease haplotype in affected
individuals. Shaded bars denote the
disease haplotype and, therefore, in-
dicate the critical disease region on
chromosome 17p13.
TABLE 1. PEDF Gene Primers User for Mutation Screening
Exon Forward 5*-3* Reverse 5*-3*
1 GCG CCT TAG GCG TAA TGG ATG CTG CTC CCT GGA GTG CCC CTG
2 GTC CTG GCT GGG GTG GCC AGG GGG TCC GGG TTC CCT GTC C
3 GGA GAC AGT CCC TGT GCA TCT C AAC TCA GCC ACG TTA CGC AG
4 GTA TAG TGT CTG TGT TCT GGG CTT CAC TCC AAC CTG GGC AAC
5 CCA GAA CCC GAG CCT GGC AGG AGG GCT ACA GAG TAA GAC TCC
6 CCC CTG ACA GCT AAG CTC CC GGT AAC GAT CCC CTG CCC CAT C
7 GGC AGC TCC TGG CTG TGT CTG GCG TTC TGC TTA GCA CAG TGG
8 GCG CCA TCC CAG CTT GCT TGC CAG GGG CAG CCT TCG TGT CCT G
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RESULTS
Twelve members of the family were typed for over 150
microsatellite markers. Significant exclusion was obtained for
all markers except those located on chromosome 17p13. Hap-
lotypes for these markers are shown in Figure 1. Two point
LOD scores between LCA/keratoconus and the markers in this
region (D17S1866, D17S849, D17S1529, D17S829, D17S796,
D17S960, D17S1796, D17S1353, and D17S1789) are summa-
rized in Table 2. The maximum LOD score of 3.21 was ob-
tained for the marker D17S829 (Table 2). Recombination
events involving markers D17S1529 and D17S960 define the
telomeric and centromeric boundaries, respectively, of the
disease region. The critical region of this disease is, therefore,
10.77 cM, between these two markers16 (Fig. 2).
The RETGC-1 gene has been physically mapped just out-
side the critical interval using a YAC contig of the region.2
However, the gene has not been genetically positioned, and
because it is known to be associated with LCA1,2 it is a possible
candidate for this phenotype. Therefore, although RETGC-1
maps just outside this region, and because this family has LCA
cosegregating with the keratoconus, we decided to screen the
family for mutations in this gene. The coding exons of this gene
were screened by heteroduplex and direct sequencing, in
affected and nonaffected members of the family. Sequencing of
the 18 exons of RETGC-1 revealed only previously reported
polymorphisms and no disease-associated mutations.
The PEDF gene has been physically mapped to the
17p13.3 between markers D17S849 and D17S938, which lies
within our critical region (Fig. 3). Because it was the possible
candidate gene for the disease, the gene was also screened for
mutations in this family. Heteroduplex and direct sequencing
of the eight exons revealed no disease-associated mutations.
In summary, homozygosity mapping in an inbred pedigree
has permitted us to identify a novel locus for LCA associated
with autosomal recessive keratoconus at chromosome 17p13.
This chromosomal region is near the locus for the Leber con-
genital amaurosis (LCA1), and overlaps with the loci for other
types of retinal degenerations, namely cone-rod dystrophy
(CORD6), cone dystrophy (CORD5), autosomal dominant ret-
initis pigmentosa (RP13), and central areolar choroidal dystro-
phy (CACD).17,18 The region has also been linked with the
anterior polar cataract.19 This fifth novel autosomal locus illus-
trates further genetic heterogeneity of the LCA phenotype.
The family investigated in the present study presented
with LCA and early onset keratoconus, cosegregating in an
autosomal recessive manner. The incidence of keratoconus
associated with LCA is between 30% and 50% above the age of
15 years.8 In a study by Elder20 of children with LCA, he
demonstrated that keratoconus was specifically linked to LCA
due to genetic factors rather than poor visual acuity per se. It
is possible that the close association of keratoconus with LCA
in this pedigree could be due to mutations in two genes in very
close proximity to each other. Alternatively, the gene defect
causing the LCA could predispose the formation of the kerato-
conus phenotype in this family.
TABLE 2. LOD Scores Calculated for the Microsatellite Markers Analyzed in this Family
Marker 0.0 0.01 0.05 0.1 0.2 0.3 0.4 Z max u max
D17S1866 20.21 20.15 0.00 0.10 0.14 0.09 0.03 0.14 0.2
D17S849 2.63 2.56 2.31 2.00 1.35 0.74 0.24 2.63 0.0
D17S1529 ‘ 1.55 1.98 1.93 1.51 0.93 0.35 1.98 0.05
D17S829 3.21 3.14 2.84 2.46 1.70 0.94 0.29 3.21 0.0
D17S796 3.20 3.11 2.78 2.36 1.55 0.80 0.23 3.20 0.0
D17S960 1.18 1.32 1.42 1.29 0.87 0.43 0.11 1.42 0.05
D17S1796 ‘ 23.20 21.73 21.08 20.48 20.19 20.05 20.05 0.4
D17S1353 ‘ 21.22 20.03 0.32 0.41 0.25 0.05 0.41 0.2
D17S1789 21.42 21.07 20.58 20.34 20.13 20.04 20.01 20.01 0.4
Values represent recombination fraction.
FIGURE 3. Diagram of chromosome 17p13 showing the critical dis-
ease regions of ocular disorders mapping to this region and the posi-
tion of the physically mapped RETGC-1 (RetGC-1) gene.
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The RETGC-1 gene, which is associated with LCA1 and
CORD6,2,21 has been excluded as a candidate in this family,
both by mutation screening and by physical exclusion indi-
cated by mapping in YACs based on the physical mapping of
the gene by Perrault et al.2 PEDF, another candidate in the
region, has also been excluded as the disease gene. The genes
associated with CORD5, RP13, and CACD are yet to be identi-
fied, however when they are they will provide additional can-
didates for this phenotype.
Heredity plays a significant role in at least a portion of
keratoconus patients. Von Ammon first described the familial
incidence of keratoconus in 1830; it has since been found that
familial incidence varies from less than 5% to as high as
20%.22,23 Topographic studies of the corneal surface to evalu-
ate 28 family members of 5 unrelated patients with keratoco-
nus found abnormalities in 50% of the family members, which
was significantly higher than in the controls.14 In another study
of the 12 patients with clinical disease, 7 of the patients had at
least one parent with evidence of subclinical keratoconus.24
These observations were mainly of dominant inheritance of the
keratoconus phenotype, recessive inheritance being much
more difficult to identify in an outbred population. Interest-
ingly, a recent report by Rabinowitz et al.25 suggests a kerato-
conus gene locus near the centromere of chromosome 21
based on nonparametric linkage analysis. The identification of
this locus in an inbred family will have a bearing on future
genetic studies of keratoconus in the general population.
The region to which this family maps is known to be one
of the most gene-rich regions of the genome due to the greatest
concentration of mapped expressed sequence tags (ESTs).26
The 15.77-cM interval between these markers contains no
well-characterized candidate genes; however, 4 ESTs identified
from the human genome transcript map (http://www.ncbi.
nlm.nih.gov/SCIENCE96/) that are expressed in the retina, 6 in
epithelial or keratinocyte cells, and 19 in nervous tissue. These
represent the best candidates available at this time. Further
analysis of these cDNA clones will be needed before mutation
screening in this family can be undertaken.
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